Stay updated on Asciminib Combo with Imatinib in CML-CP Clinical Trial
Sign up to get notified when there's something new on the Asciminib Combo with Imatinib in CML-CP Clinical Trial page.

Latest updates to the Asciminib Combo with Imatinib in CML-CP Clinical Trial page
- Check2 days agoChange DetectedThe clinical trial record for the asciminib/imatinib study is available, with detailed study, participant eligibility, treatment, outcome, location, and document information.SummaryDifference87%

- Check9 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check37 days agoChange DetectedThe footer revision label was updated from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check51 days agoChange DetectedDeleted key study documents and IPD-sharing details from the Study Documents section (including the Statistical Analysis Plan and Study Protocol) along with related metadata and keywords. This removes ready access to primary methodological materials and data-sharing information on the study page.SummaryDifference21%

- Check58 days agoChange DetectedThe website's revision identifier was updated to v3.7.0, reflecting a new build of the site. This appears to be an internal platform update rather than a change to study content or listings.SummaryDifference0.0%

Stay in the know with updates to Asciminib Combo with Imatinib in CML-CP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Asciminib Combo with Imatinib in CML-CP Clinical Trial page.